Literature DB >> 31081218

Integrative analyses of triple negative dysregulated transcripts compared with non-triple negative tumors and their functional and molecular interactions.

Farzaneh Darbeheshti1,2, Nima Rezaei3,4,5, Mahsa M Amoli6, Yaser Mansoori7,8, Javad Tavakkoly Bazzaz1.   

Abstract

Triple-negative (TN) tumors are a subtype of breast cancer with aggressive behaviors and limited targeted therapies. Microarray studies were not concerned with interactions and functional relations of dysregulated transcripts. Here, we aimed to conduct integrative strategy to analyze gene and miRNA available microarray data as well as bioinformatic analyses to catch a more inclusive picture of pivotal dysregulated transcripts and their interactions in TN tumors. Several online datasets and offline bioinformatic tools were used to detect differentially expressed (DE) transcripts, both protein and nonprotein coding, in TN compared with non-TN tumors and their functional and molecular interactions. Sixteen upregulated and 58 downregulated genes with a log fold change higher or equal to | 2 | were identified, including nine transcription factors. Coexpression network revealed EN1 as a hub gene, moreover Kaplan-Meier plotter survival analysis indicated that it was an appropriate prognostic marker for TN patients with breast cancer. Functional annotation analysis of protein-protein interaction network showed FOXM1 as an upexpressed and ESR1 as a downexpressed hub genes are suitable targets as far as antitumor protein therapy is concerned in TN breast cancers. The consensus analysis of two microRNA datasets revealed seven DE miRNAs. The gene-transcriptional factor (TF)-miRNA network revealed mir-135b and mir-29b are the hub nodes and involved in feedback loops with GATA3. This study suggests that dysregulated TFs and miRNAs have pivotal roles in regulation of TN oncotranscriptomic profile and might become both biomarkers and therapeutic targets.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  bioinformatics analysis; differentially expressed gene; hub genes; miRNAs; microarray; triple-negative breast cancer

Mesh:

Substances:

Year:  2019        PMID: 31081218     DOI: 10.1002/jcp.28804

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Identification of Key Differentially Expressed Transcription Factors in Glioblastoma.

Authors:  Gang Qin; Beiquan Hu; Xianfeng Li; Rongjie Li; Youshi Meng; Yimei Wang; Donghua Zou; Feng Wei
Journal:  J Oncol       Date:  2020-06-15       Impact factor: 4.375

2.  Identification of dysregulated miRNAs-genes network in ovarian cancer: An integrative approach to uncover the molecular interactions and oncomechanisms.

Authors:  Sepideh Kadkhoda; Farzaneh Darbeheshti; Javad Tavakkoly-Bazzaz
Journal:  Cancer Rep (Hoboken)       Date:  2020-09-04

3.  Circular RNA-associated ceRNA network involved in HIF-1 signalling in triple-negative breast cancer: circ_0047303 as a potential key regulator.

Authors:  Farzaneh Darbeheshti; Mojdeh Mahdiannasser; Zahra Noroozi; Zahra Firoozi; Behnam Mansoori; Abdolreza Daraei; Milad Bastami; Ziba Nariman-Saleh-Fam; Elahe Valipour; Yaser Mansoori
Journal:  J Cell Mol Med       Date:  2021-11-17       Impact factor: 5.310

4.  Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer.

Authors:  Jiande Wu; Tarun Karthik Kumar Mamidi; Lu Zhang; Chindo Hicks
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

5.  Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3.

Authors:  Farzaneh Darbeheshti; Elham Zokaei; Yaser Mansoori; Sima Emadi Allahyari; Zeeba Kamaliyan; Sepideh Kadkhoda; Javad Tavakkoly Bazzaz; Nima Rezaei; Abbas Shakoori
Journal:  Cancer Cell Int       Date:  2021-06-14       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.